dapivirine has been researched along with Pregnancy in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Akello, CA; Celum, C; Friedland, BA; Garcia, M; Hillier, SL; Hosek, S; Levy, L; Macdonald, P; Nair, G; Ngure, K; Palanee-Phillips, T; Reddy, K; Roberts, ST; Siziba, B; Soto-Torres, L; Szydlo, DW; van der Straten, A | 1 |
| Balkus, JE; Bunge, K; Chakhtoura, N; Chappell, CA; Fairlie, L; Gadama, L; Hillier, SL; Matrimbira, M; Mayo, AJ; Mgodi, N; Nakabiito, C; Piper, J; Richardson, B; Szydlo, DW | 1 |
| Baeten, JM; Balkus, JE; Brown, ER; Chappell, C; Harkoo, I; Jeenarain, N; Kabwigu, S; Kintu, K; Kiweewa, FM; Marzinke, M; Naidoo, L; Nair, G; Nakabiito, C; Palanee-Phillips, T; Reddy, K; Siva, S; Soto-Torres, L | 1 |
| Baeten, JM; Balkus, JE; Beigi, R; Harkoo, I; Jeenariain, N; Jiao, Y; Kabwigu, S; Kintu, K; Makanani, B; Mbilizi, Y; Mgodi, N; Moodley, J; Noguchi, LM; Palanee-Phillips, T; Piper, J; Reddy, K; Rees, H; Scheckter, R | 1 |
| Agaba, SK; Crucitti, T; De Baetselier, I; Delvaux, T; Jespers, V; Kestelyn, E; Menten, J; Schurmans, C; van de Wijgert, J; van Loen, H | 1 |
| Bekker, LG; Borremans, M; Carstens, H; Devlin, B; Gama, C; Gill, K; Isaacs, M; Kamali, A; Kapiga, S; Kotze, P; Kusemererwa, S; Louw, C; Mabude, Z; Malherbe, M; Mans, W; Miti, N; Nel, A; Ntshele, S; Nuttall, J; Parys, W; Resseler, S; Rosenberg, Z; Russell, M; Smit, M; Solai, L; Spence, P; Steytler, J; Tempelman, H; Van Baelen, B; van Niekerk, N; Van Roey, J; Vangeneugden, T; Windle, K | 1 |
| Coplan, P; Douville, K; Mitchnick, M; Romano, J; Rosenberg, Z; Temmerman, M; Van Bortel, L; Van Roey, J; Variano, B; Verstraelen, H; Weyers, S | 1 |
7 trial(s) available for dapivirine and Pregnancy
| Article | Year |
|---|---|
Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study).
Topics: Adolescent; Anti-HIV Agents; Female; HIV Infections; Humans; Pre-Exposure Prophylaxis; Pregnancy; South Africa; Uganda; Young Adult; Zimbabwe | 2023 |
DELIVER: A Safety Study of a Dapivirine Vaginal Ring and Oral PrEP for the Prevention of HIV During Pregnancy.
Topics: Emtricitabine; Female; Gestational Age; HIV Infections; Humans; Malawi; Pregnancy; Tenofovir | 2024 |
Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception.
Topics: Adolescent; Adult; Anti-Retroviral Agents; Contraception; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Double-Blind Method; Drug Interactions; Female; Follow-Up Studies; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Pregnancy; Pyrimidines; Young Adult | 2017 |
Pregnancy and Infant Outcomes Among Women Using the Dapivirine Vaginal Ring in Early Pregnancy.
Topics: Adolescent; Adult; Africa South of the Sahara; Anti-HIV Agents; Child Development; Contraceptive Devices, Female; Double-Blind Method; Female; HIV Infections; Humans; Infant, Newborn; Middle Aged; Placebos; Pregnancy; Pregnancy Outcome; Pyrimidines; Young Adult | 2018 |
The ring plus project: safety and acceptability of vaginal rings that protect women from unintended pregnancy.
Topics: Adult; Anti-HIV Agents; Contraception; Contraceptive Devices, Female; Female; HIV Infections; Humans; Menstruation; Pregnancy; Pregnancy, Unplanned; Pyrimidines; Research Design; Rwanda | 2015 |
Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women.
Topics: Adolescent; Adult; Double-Blind Method; Drug Resistance, Viral; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Incidence; Middle Aged; Pregnancy; Pyrimidines; Reverse Transcriptase Inhibitors; RNA, Viral; South Africa; Uganda; Vagina; Young Adult | 2016 |
Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring.
Topics: Administration, Intravaginal; Adult; Anti-HIV Agents; Cervix Uteri; Chromatography, Liquid; Female; Humans; Middle Aged; Placebos; Plasma; Pregnancy; Pyrimidines; Tandem Mass Spectrometry; Vagina; Young Adult | 2009 |